Firtecan pegol Unknown Status Phase 2 Trials for Metastatic Colorectal Cancer (CRC) Treatment

Indications	Status	Purpose	Phase
DBCOND0134580 (Metastatic Colorectal Cancer (CRC))	Unknown Status	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT00931840	A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma	Cetuximab (DB00002) Firtecan pegol (DB14953) Irinotecan (DB00762)